Vofopitant is a potent and selective neurokinin-1 (NK1) receptor antagonist used in research to study the role of NK1 receptors in various physiological and pathological processes, including emesis, anxiety, depression, and cognitive function; it has been investigated for its potential to enhance serotonergic neurotransmission and modulate behavioral responses related to reward and decision-making.